查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1993837

脑血管造影术市场：依影像技术、应用、病患年龄、适应症、最终使用者、国家及地区划分－全球产业分析、市场规模、市场占有率及2026年至2033年预测

Cerebral Angiography Market, By Imaging Technique, By Application, By Patient Age, By Indication, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 295 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年脑血管造影术市场价值 13.5891 亿美元，预计从 2026 年到 2033 年将以 6.70% 的复合年增长率成长。

脑血管造影术是一种影像诊断技术，透过向动脉系统注入造影剂并收集X光影像，使脑血管可视化，从而使临床医生能够以高解析度和高精度检测血管异常，例如动脉瘤、动静脉畸形和血管闭塞。其应用范围涵盖脑血管系统的详细评估，并常用于治疗计划和血管内治疗。从公共卫生角度来看，来自各国政府和世界卫生组织的权威数据表明，脑血管疾病，尤其是中风，造成了沉重的健康负担，也是推动先进神经血管成像技术需求的主要因素。世界卫生组织（WHO）已将中风列为全球主要的死亡和残疾原因之一，其发病率和盛行率仍然居高不下，凸显了精准血管成像在医疗保健系统和临床路径中的核心作用。

脑血管造影术市场－市场动态

全球中风和脑血管疾病负担日益加重

中风和其他脑血管疾病发生率的上升是推动脑血管造影术需求成长的主要因素。脑血管造影术广泛用于观察脑血管，诊断动脉瘤、血管畸形和动脉阻塞等可能导致中风的异常情况。随着全球中风病例数的增加，医疗系统需要更先进的影像技术来支援精准诊断和治疗方案的发展。根据政府和公共卫生统计数据，中风是全球面临的重大负担。世界卫生组织（WHO）报告称，全球每年新增数百万例中风病例，数百万人患有中风后遗症。该组织还预测，四分之一的成年人一生中会经历中风，凸显了神经系统疾病影像检查日益增长的需求。由于脑血管血管造影术能够提供脑血管的详细影像，医院和神经血管中心越来越多地利用这项技术来识别血管异常并制定介入治疗方案。随着世界各地医疗统计数据不断报告中风及相关血管疾病的发病率，对精确的神经血管成像技术的需求日益增长，这可能会加速医疗机构采用脑血管造影术系统。

脑血管造影术市场－市场区隔分析：

全球脑血管血管造影术市场按影像技术、应用、患者年龄、适应症、最终用户和地区进行细分。

在市场框架内，根据影像技术可划分出四个细分市场：数位减影血管摄影检查（DSA）、磁振血管摄影检查（MRA）、电脑断层血管摄影检查（CTA）和导管血管摄影检查。数位减影血管摄影检查（DSA）能够提供脑血管的高解析度即时影像，因此在脑血管造影术市场中占据重要地位，特别适用于识别动脉瘤、动静脉畸形和血管狭窄。虽然磁振血管造影术（MRA）和电脑断层血管血管造影术（CTA）等无创技术正日益普及，但DSA对于复杂病例和手术规划仍然至关重要。公共卫生指南也支持其应用。美国心臟协会（AHA）报告称，美国每年约有10万例中风，凸显了精准血管成像的必要性。英国国家医疗服务体系 (NHS) 也建议在介入治疗过程中需要精确血管定位的病例中使用数位减影血管摄影 (DSA)。这些因素共同凸显了 DSA 在临床实务中持续的重要性。

根据应用领域，市场结构可分为三个部分：神经内科、神经外科和介入放射学。神经内科领域已成为脑血管血管造影术市场的关键细分领域。这是因为脑血管摄影广泛用于诊断和后续观察脑血管疾病，例如中风、动脉瘤和动静脉畸形。脑血管造影术可为神经科提供脑血管的详细影像，从而支持神经血管疾病的快速诊断和有效治疗。早期发现异常是预防併发症的关键。公共卫生数据也强调了这项需求。根据美国疾病管制与预防中心 (CDC) 统计，美国每年有数百万人发生中风，其中数十万人为首次中风。同时，世界卫生组织 (WHO) 指出，脑血管疾病是全球数百万人死亡的原因。这些数据凸显了神经影像学在临床护理和公共卫生规划中的重要性，并强调了神经病学作为推动脑血管造影术需求的主要应用领域的重要性。

脑血管造影术市场—区域趋势

在全球脑血管血管造影术市场中，北美和亚太地区占据主导地位，这主要归因于医疗基础设施、疾病盛行率和技术应用方面的差异。北美占据最大的市场份额，约为41.8%，这得益于其先进的医疗体系、神经影像技术的广泛应用以及对脑血管疾病诊断和治疗的大量投入。美国和加拿大的高卒中发病率，加上CT和MRI扫描仪的广泛使用，维持了对精细血管成像的需求。亚太地区虽然目前的市场份额较小，但由于中国和印度等国家医疗基础设施的不断完善、人们对卒中和神经血管疾病的认识不断提高，以及政府为改善先进诊断技术的可及性而采取的倡议，该地区正经历快速增长。庞大的人口基数和不断上升的卒中病例数也推动了这些因素的发展。这些趋势凸显了医疗体系、疾病负担和公共部门的支持如何影响脑血管血管造影术在区域层面的应用和普及。

脑血管造影术市场—各国市场洞察

在全球范围内，美国在脑血管造影术市场占据着举足轻重的地位，这主要得益于先进神经影像工具的广泛应用以及对精细血管诊断的需求。美国面临中风和其他脑血管疾病带来的沉重负担。根据美国疾病管制与预防中心（CDC）统计，美国每年有数十万人发生中风，其中约有数十万人是首次中风。这些病例中约87%为缺血性中风，需要精确的影像检查才能进行有效治疗。这些数据凸显了脑血管摄影的巨大需求。脑血管摄影能够侦测脑血管系统的异常情况，并提供脑血管造影术的详细影像，进而辅助临床决策。高发病率、完善的医疗基础设施以及先进影像系统的普及，共同巩固了美国在全球市场的主导地位。

目录

第一章：脑血管造影术市场概览

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章：脑血管造影术的主要市场趋势

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 未来市场趋势

第四章：血管造影术产业的分析

  • PEST分析
  • 波特五力分析
  • 市场成长前景展望图
  • 管理体制分析

第五章：脑血管血管造影术市场：地缘政治张力加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：血管造影术市场现状

  • 脑血管造影术市场占有率分析，2025年
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

第七章：脑血管血管造影术市场：依影像技术划分

  • 概述
    • 细分市场占有率分析：依诊断影像技术划分
    • 数位减影血管摄影检查（DSA）
    • 磁振血管造影术（MRA）
    • 电脑断层血管造影术（CTA）
    • 导管血管造影术
    • 术中血管造影术

第八章：脑血管造影术市场：依应用领域划分

  • 概述
    • 基于细分市场的市场份额分析：按应用领域
    • 神经病学
    • 神经外科
    • 介入放射学
    • 其他的

第九章：血管造影术市场：依病患年龄划分

  • 概述
    • 细分市场占有率分析：依患者年龄划分
    • 成年患者
    • 儿童患者

第十章：血管造影术市场：依适应症划分

  • 概述
    • 基于细分市场的市占率分析：按适应症
    • 中风
    • 动脉瘤
    • 动静脉畸形（AVM）
    • 颈动脉疾病
    • 脑肿瘤

第十一章：脑血管血管造影术市场：依最终用户划分

  • 概述
    • 基于细分市场的市场份额分析：按最终用户划分
    • 医院
    • 诊断影像中心
    • 神经科专科诊所
    • 研究机构
    • 门诊手术中心

第十二章：脑血管血管造影术市场：按地区划分

  • 介绍
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 主要製造商：欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他欧洲国家
  • 亚太地区
    • 概述
    • 主要製造商：亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他亚太国家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他拉丁美洲国家
  • 中东和非洲
    • 概述
    • 主要生产商：中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他中东和非洲国家

第十三章：主要供应商分析：血管造影术产业

  • 竞争基准
    • 竞争对手仪錶板
    • 竞争定位
  • 公司简介
  • GE医疗
  • 西门子医疗内部
  • Koninklijke Philips NV
  • 岛津公司
  • Canon Medical Systems Corporat
  • 三星麦迪逊
  • St. Jude Medical, Inc.
  • 日立医疗株式会社
  • Terumo Corporation
  • Medtronic plc
  • 打击者公司
  • AngioDynamic, Inc.
  • Penumbra, Inc.
  • MicroPort Scientific Corporation
  • Cordis
  • Cook Medical LLC

第十四章：AnalystView 的全景视图

简介目录
Product Code: ANV6196

Cerebral Angiography Market size was valued at US$ 1,358.91 Million in 2025, expanding at a CAGR of 6.70% from 2026 to 2033.

Cerebral angiography is a diagnostic imaging technique in which a contrast agent is introduced into the arterial system and X ray images are acquired to visualize the blood vessels of the brain, enabling clinicians to detect vascular abnormalities such as aneurysms, arteriovenous malformations, and occlusions with high resolution and precision. Its application extends to a detailed assessment of cerebral vasculature and is often integrated into treatment planning and endovascular interventions. At the public health level, authoritative government and global health data indicate that cerebrovascular diseases, particularly stroke, constitute a substantial health burden and a key driver of demand for advanced neurovascular imaging; stroke is recognized by the World Health Organization as one of the leading causes of death and disability globally, demonstrating persistent incidence and prevalence that reinforce the central role of accurate vascular imaging in health systems and clinical pathways.

Cerebral Angiography Market- Market Dynamics

Increasing Global Burden of Stroke and Cerebrovascular Diseases

The rising prevalence of stroke and other cerebrovascular conditions is a major factor supporting the demand for cerebral angiography procedures. Cerebral angiography is widely used to visualize blood vessels in the brain and diagnose abnormalities such as aneurysms, vascular malformations, and arterial blockages that can lead to stroke. As the number of stroke cases increases globally, healthcare systems require more advanced imaging procedures to support accurate diagnosis and treatment planning. Government and public health statistics indicate a significant global burden of stroke. According to the World Health Organization (WHO), millions of new stroke cases occurred worldwide, and about millions of people were living with stroke globally. The organization also reports that one in four adults is expected to experience a stroke during their lifetime, highlighting the growing need for diagnostic imaging in neurological care. Because cerebral angiography provides detailed images of cerebral blood vessels, hospitals and neurovascular centers increasingly use it for confirming vascular abnormalities and planning interventional procedures. As the incidence of stroke and related vascular disorders continues to be reported in national health statistics, the need for accurate neurovascular imaging technologies is likely to support the adoption of cerebral angiography systems in healthcare facilities.

Cerebral Angiography Market- Segmentation Analysis:

The Global Cerebral Angiography Market is segmented on the basis of Imaging Technique, Application, Patient Age, Indication, End User, and Region.

The market framework identifies four segments based on imaging technique: Digital Subtraction Angiography (DSA), Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), and Catheter Angiography. Digital Subtraction Angiography (DSA) continues to represent a key segment in the cerebral angiography market due to its ability to provide highly detailed, real-time images of brain blood vessels, making it particularly useful for identifying aneurysms, arteriovenous malformations, and vascular narrowing. While non-invasive techniques such as Magnetic Resonance Angiography (MRA) and Computed Tomography Angiography (CTA) are gaining popularity, DSA remains essential for complex cases and surgical planning. Public health guidance supports its use: the American Heart Association reports approximately lakhs of strokes in the U.S. each year, emphasizing the need for precise vascular imaging, and the UK's National Health Service recommends DSA for cases requiring accurate vascular mapping during interventions. These factors collectively underscore DSA's continued prominence in clinical practice.

The market framework identifies three segments based on application: Neurology, Neurosurgery, and Interventional Radiology. The Neurology segment emerges as a significant segment in the cerebral angiography market, as it is widely used to diagnose and monitor cerebrovascular conditions such as stroke, aneurysms, and arteriovenous malformations. Cerebral angiography provides neurologists with detailed images of brain blood vessels, supporting timely diagnosis and effective management of neurovascular disorders, with early detection of abnormalities being key to preventing complications. Public health data underscores this need: the Centre for Disease Control and Prevention (CDC) reports that people in the U.S. experience a stroke each year, including approximately lakhs of first-time cases, while the World Health Organization (WHO) notes that cerebrovascular diseases cause over millions of deaths globally. These figures highlight the importance of neurological imaging in both clinical care and public health planning, reinforcing neurology as the primary application driving demand for cerebral angiography.

Cerebral Angiography Market- Geographical Insights

In the global cerebral angiography market, North America and Asia Pacific are notable leaders due to differences in healthcare infrastructure, disease prevalence, and technology adoption. North America holds the largest share, around 41.8 %, driven by advanced healthcare systems, widespread availability of neuroimaging technologies, and significant investment in diagnostic and interventional care for cerebrovascular diseases; the high incidence of stroke in the U.S. and Canada, combined with the extensive use of CT and MRI scanners, sustains demand for detailed vascular imaging. Asia Pacific, while smaller in current share, is experiencing rapid growth due to expanding healthcare infrastructure in countries like China and India, increasing awareness of stroke and neurovascular conditions, and government initiatives to improve access to advanced diagnostics, supported by large populations and a rising number of stroke cases. These trends highlight how healthcare capacity, disease burden, and public sector support influence the adoption and expansion of cerebral angiography across regions.

Cerebral Angiography Market- Country Insights

Worldwide, the United States maintains a strong presence in the cerebral angiography market, driven by the adoption of sophisticated neuroimaging tools and the need for detailed vascular diagnosis. The country faces a considerable burden of stroke and other cerebrovascular conditions; the Centre for Disease Control and Prevention (CDC) reports that over lakhs of people in the U.S. experience a stroke each year, including approximately lakhs of first-time strokes, with about 87 % being ischemic strokes that require precise imaging for effective treatment. These figures highlight the demand for cerebral angiography, which offers detailed visualization of brain blood vessels to detect abnormalities and assist in clinical decision-making. The combination of high disease prevalence, robust healthcare infrastructure, and access to advanced imaging systems reinforces the United States leading position in the global market.

Cerebral Angiography Market- Competitive Landscape:

In the competitive landscape of the cerebral angiography market, a number of established medical imaging and device companies offer advanced angiography systems, software, and supporting technologies for detailed visualization of cerebral blood vessels and efficient clinical workflows. Leading global players such as GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems are known for their comprehensive cerebral angiography solutions and continuous improvements in imaging quality and clinical support. Other important contributors, including Shimadzu Corporation, Boston Scientific Corporation, AngioDynamics, and Medtronic, add variety to the market with specialized products designed for diverse healthcare environments. These companies sustain their market presence through ongoing research and development, wide distribution channels, and product updates that address clinical demands, particularly for diagnosing and managing neurovascular diseases like stroke, which remains a priority for public health authorities and national healthcare planning.

Recent Developments:

In December 2025, Stratasys announced full commercial availability of its RadioMatrix radiopaque 3D printing material across the U.S., enabling healthcare providers and researchers to create patient-specific models with tunable X-ray visibility for imaging and training. This development is expected to enhance medical education, improve procedural planning, and support more accurate simulations, ultimately contributing to better patient outcomes and advancing innovation in medical imaging technologies.

In February 2025, the FDA granted 510(k) clearance to RapidAI's Lumina 3D software, which delivers AI-powered 3D CTA reconstructions of head and neck scans within minutes, improving visualization and accelerating neuroradiology workflow. This advancement is set to streamline diagnostic processes, enhance clinical decision-making, and support faster, more precise patient care in neuroradiology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CEREBRAL ANGIOGRAPHY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GE Healthcare
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • Shimadzu Corp.
  • Canon Medical Systems Corporation
  • Samsung Medison
  • St. Jude Medical, Inc.
  • Hitachi Medical Corporation
  • TERUMO Corporation
  • Medtronic plc
  • Stryker Corporation
  • AngioDynamic, Inc.
  • Penumbra, Inc.
  • MicroPort Scientific Corporation
  • Cordis
  • Cook Medical LLC

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY IMAGING TECHNIQUE- MARKET ANALYSIS, 2020 - 2033

  • Digital Subtraction Angiography (DSA)
  • Magnetic Resonance Angiography (MRA)
  • Computed Tomography Angiography (CTA)
  • Catheter Angiography
  • Intraoperative Angiography

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Neurology
  • Neurosurgery
  • Interventional Radiology
  • Others

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY PATIENT AGE- MARKET ANALYSIS, 2020 - 2033

  • Adult Patients
  • Pediatric Patients

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY INDICATION- MARKET ANALYSIS, 2020 - 2033

  • Stroke
  • Aneurysm
  • Arteriovenous Malformation (AVM)
  • Carotid Artery Disease
  • Brain Tumors

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Hospitals
  • Diagnostic Imaging Centers
  • Specialty Neurology Clinics
  • Research Institution
  • Ambulatory Surgical Centers

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cerebral Angiography Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cerebral Angiography Market Snippet by Imaging Technique
    • 2.1.2. Cerebral Angiography Market Snippet by Application
    • 2.1.3. Cerebral Angiography Market Snippet by Patient Age
    • 2.1.4. Cerebral Angiography Market Snippet by Indication
    • 2.1.5. Cerebral Angiography Market Snippet by End User
    • 2.1.6. Cerebral Angiography Market Snippet by Country
    • 2.1.7. Cerebral Angiography Market Snippet by Region
  • 2.2. Competitive Insights

3. Cerebral Angiography Key Market Trends

  • 3.1. Cerebral Angiography Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cerebral Angiography Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cerebral Angiography Market Opportunities
  • 3.4. Cerebral Angiography Market Future Trends

4. Cerebral Angiography Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cerebral Angiography Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cerebral Angiography Market Landscape

  • 6.1. Cerebral Angiography Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cerebral Angiography Market - By Imaging Technique

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Imaging Technique, 2025 & 2033 (%)
    • 7.1.2. Digital Subtraction Angiography (DSA)
    • 7.1.3. Magnetic Resonance Angiography (MRA)
    • 7.1.4. Computed Tomography Angiography (CTA)
    • 7.1.5. Catheter Angiography
    • 7.1.6. Intraoperative Angiography

8. Cerebral Angiography Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Neurology
    • 8.1.3. Neurosurgery
    • 8.1.4. Interventional Radiology
    • 8.1.5. Others

9. Cerebral Angiography Market - By Patient Age

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Patient Age, 2025 & 2033 (%)
    • 9.1.2. Adult Patients
    • 9.1.3. Pediatric Patients

10. Cerebral Angiography Market - By Indication

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Indication, 2025 & 2033 (%)
    • 10.1.2. Stroke
    • 10.1.3. Aneurysm
    • 10.1.4. Arteriovenous Malformation (AVM)
    • 10.1.5. Carotid Artery Disease
    • 10.1.6. Brain Tumors

11. Cerebral Angiography Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Diagnostic Imaging Centers
    • 11.1.4. Specialty Neurology Clinics
    • 11.1.5. Research Institution
    • 11.1.6. Ambulatory Surgical Centers

12. Cerebral Angiography Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Cerebral Angiography Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Cerebral Angiography Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Cerebral Angiography Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Cerebral Angiography Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Cerebral Angiography Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Cerebral Angiography Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
  • 13.3. GE Healthcare
  • 13.4. Siemens Healthineers
  • 13.5. Koninklijke Philips N.V.
  • 13.6. Shimadzu Corp.
  • 13.7. Canon Medical Systems Corporation
  • 13.8. Samsung Medison
  • 13.9. St. Jude Medical, Inc.
  • 13.10. Hitachi Medical Corporation
  • 13.11. TERUMO Corporation
  • 13.12. Medtronic plc
  • 13.13. Stryker Corporation
  • 13.14. AngioDynamic, Inc.
  • 13.15. Penumbra, Inc.
  • 13.16. MicroPort Scientific Corporation
  • 13.17. Cordis
  • 13.18. Cook Medical LLC

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us